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Abstract
Iron is essential in the retina because the heme-containing enzyme guanylate cyclase modulates phototransduction in rods
and cones. Transferrin endocytosis is the classical pathway for obtaining iron from the blood circulation in the retina.
However, the iron storage protein ferritin has been also recently proposed as an iron carrier. In this study, the presence of
Scara5 and its binding to L-ferritin was investigated in the retina. Our results showed that Scara5, the specific receptor for L-
ferritin, was expressed in mouse and human retinas in many cell types, including endothelial cells. Furthermore, we showed
that intravenously injected ferritin crossed the blood retinal barrier through L-ferritin binding to Scara5 in endothelial cells.
Thus, suggesting the existence of a new pathway for iron delivery and trafficking in the retina. In a murine model of
photoreceptor degeneration, Scara5 was downregulated, pointing out this receptor as a potential player implicated in
retinopathy and also as a possible therapeutic target.
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Introduction
Iron is required in cellular metabolism due to its participation in
various heme and non-heme-containing enzymes [1]. The retina
specifically needs iron because the enzyme guanylate cyclase
assures the synthesis of cGMP, which acts as the second messenger
in the phototransduction pathway [2]. Moreover, the extensive
membrane biogenesis, necessary to continually replenish shed
photoreceptor outer segments, also requires iron as an essential
cofactor [3]. The retina obtains iron from the blood circulation. It
is accepted that serum transferrin, the classical iron transporter
protein, binds to its receptor on the surface of retinal pigment
epithelial cells (RPE) and vascular endothelial cells and, in this
way, free iron is delivered to the retina [4–6].
Involvement of iron in oxidative retinal damage has become
clear [7]. The retina is constantly exposed to photo-oxidative
stress, and it is especially vulnerable to damaging free radicals
generated in the presence of the ferrous iron [8,9]. Iron
accumulation is associated with several retinopathies, including
retinal degeneration [10], diabetic retinopathy [11], glaucoma
[12], photoreceptor damage in uveitis [13], light-induced retinop-
athy [14], and age-related macular degeneration [15]. Despite its
importance, iron influx and cell type involved in iron accumula-
tion and storage mechanisms in the retina are not completely
understood.
Ferritin is an iron handling protein ubiquitously distributed,
known for its role in iron storage and detoxification [16]. Ferritin is
composed of twenty-four subunits of heavy (H) and light (L)
chains, whose ratio is variable in the different tissues [17]. The two
chains of ferritin have complementary functions: H-ferritin
possesses ferroxidase activity and enables the oxidation of iron;
L-ferritin induces iron nucleation within the central core of the
protein. Both ferritins can independently incorporate iron [18].
Recently, serum ferritin has been proposed as a new iron carrier
protein [19]. Serum ferritin is composed mostly, but not
exclusively, of L-ferritin [20,21]. The advantage of serum ferritin
as iron carrier, compared to serum transferrin, is that one
molecule of transferrin only binds to two iron atoms, while serum
ferritin can incorporate up to 4.500 iron atoms [19].
The blood-retinal barrier (BRB) prevents free access of blood-
borne molecules to the retina [22]. Thus, specific receptors are
required in order to allow serum ferritin influx into the retina.
Ferritin specifically binds to several receptors: L-ferritin binds to
Scara5 [23], while H-ferritin binds to TIM-2 [24,25] and
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transferrin receptor 1 (TfR1) [26]. Nevertheless, neither Scara5
nor TIM-2 has so far been identified in the retina.
In this study, the presence of Scara5 and its binding to L-ferritin
was investigated in the retina. Since iron transporters are
frequently regulated by iron cytosolic levels, Scara5 expression
was also evaluated in iron repletion conditions, and during
degenerative retinopathy.
Our results showed that Scara5 is present in the mouse and
human retina, and that serum ferritin can cross the BRB through
its binding to Scara5 receptors. This pathway may constitute an
important mechanism of iron traffic in the retina that is altered
during experimental retinopathy.
Material and Methods
Ethics statement
Animal care and experimental procedures were approved by
the Comissio´ d9E`tica en l9Experimentacio´ Animal I Humana
(CEEAH-Permit Number: 1666) of Universitat Auto`noma de
Barcelona (UAB). Mice were anesthetized with an intraperitoneal
injection of a ketamine/xylazine mixture. Euthanasia was
performed by inhalation with an overdose of isoflurane. For this
study 45 mice were used.
Human eye samples were acquired from voluntary body
donations to the Faculty of Medicine at UAB for teaching and
research, in accordance with the Catalonian law (DECRET 297/
1997, de 25 de Novembre). For this reason, it was not necessary
specific ethics committee approval. Written informed consent was
obtained from all adult participants. We received human eye
samples without knowledge of the donor’s identity, only biological
data, such as sex and age, were available. Results obtained from
the same human retinas were previously published [27,28].
Animals
Forty five CD1 adult mice were used. Animals were fed ad
libitum with a standard diet (Panlab SL, Barcelona, Spain).
Table 1. Primer pairs sequences for quantitative q-RT- PCR.1–3
Gene symbol Full gene name Acc. Number 1 Primer pairs3 (59-39) Exons spanned Product size (bp)
SCARA5 scavenger receptor class A,
member 5 (putative)
NM_001168318.1;
NM_028903.2
F: agg agg gaa agc cag gta gc
R: ccc cta gct tcc cat cat ca
5–6 108
TFRC transferrin receptor NM_011638.4 F: tgt gaa gct cat tgt gaa aaa cg
R: gcg tct ctc tgg gct cct ac
10–11 117
TRF transferrin NM_133977.2 F: arc cga tgc tat gac ctt gg
R: ccc ttc ttt acc aca gcc aca
3–4 144
ACTB2 actin, beta NM_007393.3 F: tgt tac caa ctg gga cga ca
R: ggg gtg ttg aag gtc tca aa
3–4 165
GAPDH2 glyceraldehyde-3-phosphate
dehydrogenase
NM_008084.2 F: cgt gtt cct acc ccc aat gt
R: gcc tgc ttc acc acc ttc tt
5–6 95
1Entrez Gene, National Center for Biotechnology Information (NCBI).
2housekeeping genes.
3 F: forward primer and R: reverse primer.
doi:10.1371/journal.pone.0106974.t001
Figure 1. Scara5 was expressed in mouse retinal cells. A: The expression of SCARA5 mRNA in the retina was evaluated by q-RT-PCR. Agarose
gel electrophoresis of q-RT-PCR products confirmed that SCARA5 single amplicon with 108 bp was generated. ACTB and GAPDH were used as
housekeeping genes. B: Western blotting analysis revealed a specific band with a molecular weight of 48 KDa, confirming the presence of Scara5
receptors in the retina. a-tubulin was used as a loading control. C: Retinal immunolabeling with a specific antibody in a histological section, along the
eye axis through the optic disc and cornea, showed that Scara5 was expressed throughout the retina, mainly at the level of ganglion cell layer, inner
nuclear layer, outer nuclear layer and RPE. D: Immunohistochemical negative control, where the primary antibody was omitted. Ret, retina; Liv, liver; -,
no-template control; GL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium. Scale bars: 28 mm (A);
28 mm (B).
doi:10.1371/journal.pone.0106974.g001
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Figure 2. Scara5 was found both in the nucleus and cytoplasm of retinal cells. A: Scara5 expression was observed at nuclear (arrow) and
cytoplasmic (arrowhead) compartments in mouse retinal histological sections immunolabeled with a specific anti-Scara5 antibody. Nuclei were
marked with Hoechst Stain Solution. B: Western blotting analysis of nuclear and cytoplasmic protein fractions samples confirmed the nuclear and
cytoplasmic Scara5 content in the retinal cells. a-tubulin was used as a loading control. Topoisomerase-I (Topo I) was used to assure that nuclear
protein was not present in the cytoplasmic fraction. GL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. Scale bar: 28 mm.
doi:10.1371/journal.pone.0106974.g002
Figure 3. Scara5 was expressed in retinal neurons. A: Labeled retinal ganglion cells with Brn3a showed a nuclear intense Scara5 signal. B: PKC
positive bipolar cells expressed Scara5. C: Photoreceptors presented a high expression of Scara5. The labeling with PNA lectin, which is specific for
cone inner segments, showed a more intense signal in cones than in rods. Nuclei were counterstained with ToPro3. ga, retinal ganglion cells; bi,
bipolar cells; co, cone inner segments. Scale bars: 3,8 mm (A); 5,4 mm (B); 12,5 mm (C).
doi:10.1371/journal.pone.0106974.g003
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Animal care and experimental procedures were approved by the
Ethics Committee in Animal and Human Experimentation of the
Autonomous University of Barcelona.
Mouse retinopathy model experiments
Two groups of 6 mice each were intraperitoneally injected with
100 mg/kg of sodium iodate (NaIO3; Sigma-Aldrich, St Louis,
MO, USA) in phosphate buffer and euthanatized 24 and 48 hours
after treatment, as previously described [29]. A group injected only
with physiological saline solution (PSS) was used as control.
Retinas were obtained and processed according to the specific
protocol for western blotting and immunohistochemistry.
Ferritin intravenous administration experiments
Horse spleen ferritin (HSF; Sigma-Aldrich), 40 mg/mL, was
injected in 8 animals. A group of four animals injected only with
PSS was used as control. Six hours after HSF injection, retinas
were obtained and processed according to the specific protocol for
q-RT-PCR, western blotting and immunohistochemistry.
Human retinas
Retinas from three healthy donors, two female and one man of
42 (D1), 86 (D3) and 78 (D2)-years-old, respectively, were formalin
fixed and processed for immunohistochemistry.
RNA isolation and cDNA preparation
Eyes were enucleated in an RNAse-free environment. Retinas
were quickly and carefully dissected in sterile RNAse-free cold
water solution, transferred and submerged immediately into
350 ml of RLT lysis buffer (Qiagen Inc, Hilden, Germany),
homogenized with an Ultra-Turrax homogenizer (IKA-Labor-
technik, Staufen, Germany). Total retinal RNA from each mouse
was extracted using the RNeasy Mini Kit (Qiagen Inc) according
to the manufacturer’s protocol. To eliminate possible genomic
DNA contamination, one column digestion of residual DNA was
accomplished using an accessory RNase-free DNase set to use with
RNeasy columns (Qiagen Inc), as the manufacturer’s instructions.
The total RNA was quantified by measuring the absorbance at
260 nm using a NanoDrop ND-2000c spectrophotometer (Nano-
Drop, Thermo Fisher Scientific, Willmington, DE, USA), and the
purity was assessed by determining the ratio of the absorbance at
260 and 280 nm (NanoDrop), which indicated that all 260/
280 nm ratios were.1.9. Integrity of the RNA was verified by
visualization of the 28S and 18S ribosomal bands on 2% agarose
gels containing ethidium bromide. For the RT-PCR, the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems,
Foster City, CA, USA) was utilized for synthesis of single stranded
cDNA. Briefly, each RT reaction contained 700 ng of extracted
total RNA sample using MultiScribe Reverse Transcriptase
according to the manufacturer’s instructions, with an RNase
Figure 4. Scara5 was expressed in retinal glia. A: Labeled astrocytes with GFAP showed Scara5 expression. B: GS positive Mu¨ller cells presented
intense Scara5 signal both at the nuclear and cytoplasmic compartments. C: Microglial cells revealed a more intense Scara5 signal in nucleus than in
cytoplasm. Nuclei were counterstained with ToPro3. as, astrocyte; mu¨, Mu¨ller cell; mi, microglial cell. GL, ganglion cell layer; INL, inner nuclear layer;
ONL, outer nuclear layer. Scale bars: 33 mm (A); 33 mm (B); 14,7 mm (C).
doi:10.1371/journal.pone.0106974.g004
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inhibitor in a final volume of 20 ml. The program is the following:
25uC 10 min, 37uC 120 min, 85uC 5 min. The cDNA aliquots
obtained were stored at 220uC until further analysis.
Quantitative real-time PCR analysis of gene expression
According to Mus musculus gene sequences, the primers were
designed and when possible to across exon-exon boundaries using
Primer3 (http://frodo/wi.mit.edu/primer3/) and Primer Express
Software v. 2.0 (Applied Biosystems). The primer sequences,
products lengths, and NCBI accession numbers tested are
provided in Table 1. Primers were synthesized commercially by
NZYTech (Lisbon, Portugal). Sequence homology searches were
performed using the Basic Local Alignment Search Tool (Blast)
‘‘http://www.ncbi.nlm.nih.gov/blast’’, to confirm gene identity of
amplified fragments and that these primers matched only the
sequence to which they were designed. To ensure optimal DNA
polymerization efficiency, the amplicon length ranged between 95
and 165 bp. Before performing q-RT-PCR analysis, a final-point
PCR was carried out for all genes to test the primers and verify the
amplified products. PCR products were sequenced and homology
searches were performed with Blast. Real time polymerase
reaction was used to assess the retinal expression of scavenger
receptor class A member 5 (putative) (SCARA5), transferrin
receptor 1 (TFRC) and transferrin (TRF).
Gene relative quantification was carried out using MicroAmp
Optical 96-well plates (Applied Biosystems) in a StepOnePlus
thermocycler (Applied Biosystems) in standard cycling conditions.
The 12.5 ml PCR reaction mixtures contained 6.25 ml of 26Power
SYBR Green PCR Master Mix (Applied Biosystems), 160 nM of
each primer, and 2 ml of diluted cDNA as template. No
transcription and no template samples were used as controls.
The primer specificity and the formation of primer-dimers were
confirmed by melt curve analysis and agarose gel electrophoresis.
Measurements of each sample for each gene were made in
duplicate and the relative quantification for each target gene was
calculated using the normalization factor which was the geometric
mean of beta-actin (ACTB)/glyceraldehyde-3-phosphate dehydro-
genase (GAPDH) genes according to the 22DDCt method [30].
Statistical analysis of relative expression values was performed
using Rest 2009 V2.0.13 software (http://www.REST.de.com).
Western blot analysis
For western blot analysis, animals were perfused with phosphate
buffered saline solution (PBS) through the aorta to remove the
traces of blood transferrin and serum ferritin. Eyes were
enucleated, and retinas dissected and homogenized in modified
RIPA buffer (25 mM Tris base, pH 8.2, 150 mM NaCl, 0.5% NP-
40, 0.1% SDS, 0.5% sodium deoxycholate), containing protease
inhibitor cocktail tablets (cOmplete Mini, Roche, Basel, Switzer-
land). Nuclear and cytoplasmic protein fraction samples were
obtained using the ReadyPrep Protein Extraction Kit (Cytoplas-
mic/Nuclear) (Bio-Rad, Hercules, CA, USA) according to
manufacturer’s instructions. Livers were homogenized with an
Ultra-Turrax (Ika-Labortechnik) in the lysis buffer described.
Protein concentrations were determined with BCA protein assay
reagent [31] and Bradford assay method [32]. For immunoblot-
ting, lysates were resuspended in SDS–PAGE loading buffer
(140 mM Tris base, pH 6.7, 6.8% SDS, 33% glycerol, 0.004%
Figure 5. L-ferritin expression in mouse retina. A: The expression of FTL1 mRNA in the retina was evaluated by q-RT-PCR. Agarose gel
electrophoresis of q-RT-PCR products confirmed that FTL1 single amplicon with 144 bp was generated. ACTB and GAPDH were used as housekeeping
genes. B: Western blotting analysis showed a specific band with a molecular weight of 19 KDa, confirming the presence of L-ferritin in the retina. a-
tubulin was used as a loading control. C: Analysis of nuclear and cytoplasmic protein fractions samples showed that L-ferritin was present in both
cellular compartments. a-tubulin was used as a loading control. Topo I was used to assure that nuclear protein was not present in the cytoplasmic
fraction sample. D: As expected, L-ferritin immunolabeling distribution pattern (arrows) was in accordance with the Scara5 signal (arrows) in paraffin-
embedded retinal sections. Ret, retina; Liv, liver; -, no-template control; GL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. Scale
bar: 29 mm.
doi:10.1371/journal.pone.0106974.g005
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bromophenol), ultrasonicated for 10 min, heated at 95uC for
15 min, and centrifuged at 14000 rpm/8000 g for 10 min. 5% b-
mercaptoethanol was added to the supernatants, followed by
incubation on ice for 20 min. Prior to loading, protein samples
were heated at 95uC for another 5 min, and were separated in a
12% pre-cast SDS-PAGE gel (Bio-Rad). Proteins were transferred
to an Immobilon-P polyvinylidene fluoride (PDVF) membrane
(Merck Millipore, Billerica, MA, USA) for antibody probing. The
following primary antibodies were used: rabbit anti-mouse Horse
Spleen Ferritin (Sigma-Aldrich) at 1:2000 dilution, rabbit anti-
mouse GFAP (DAKO, Glostruo, Denmark) at 1:3000 dilution;
rabbit anti-mouse L- ferritin (Abcam, Cambridge, UK) at 1:2000
dilution; rabbit anti-mouse Scara5 (Abcam) at 1:1000 dilution,
rabbit anti-mouse Topoisomerase I (Abcam) at 1:500 dilution;
Figure 6. Retinal vasculature expressed Scara5 receptors. A: Cells surrounded by the blood basement membrane marked with collagen IV
showed intense Scara5 signal. B and C: Dual immunolabeling with Scara5 and with a-SMA and CD34, respectively, confirmed that vascular smooth
muscle cells and endothelial cells expressed Scara5 receptors. D: Whole mount retinas immunohistochemically marked with collagen IV and Scara5
showed that perivascular astrocyte-like cells intensively expressed Scara5 in their vascular end-feet. Nuclei were counterstained with ToPro3. en,
endothelial cell; sm, smooth muscle cell; v, blood vessel; as: astrocyte-like cell. Scale bars: 10 mm (A); 9 mm (B); 9 mm (C); 12 mm (D).
doi:10.1371/journal.pone.0106974.g006
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rabbit anti-mouse transferrin (Acris, Herford, Germany), at
1:10000 dilution, and rabbit anti-mouse transferrin receptor 1
(Abcam) at 1:1000. All primary antibodies were incubated in
blocking buffer of 5% non-fat milk powder in PBT (Phosphate
buffered saline, 0.05% Tween-20) for 2 hours at room tempera-
ture. After washing with PBT, membranes were incubated for
30 min at room temperature with a horseradish peroxidase-
conjugated goat anti-rabbit IgG secondary antibody (Southern
Biotech, Birmingham, AL, USA) at 1:75000 dilution in blocking
buffer. Following washing with PBT, detection was performed by
enhanced chemiluminescence using Luminata Crescendo (Merck
Millipore). A rabbit anti-mouse alpha-tubulin primary antibody
(Abcam) at 1:600000 was used to normalize blot loading.
Immunohistochemistry
Eyes embedded in paraffin were sectioned (3 mm) along the eye
axis through the optic disc and cornea, deparaffinized and
rehydrated. Whole-mount retinas were fixed in 10% neutral
buffered formalin for 2 hours at 4uC. After they were washed in
PBS, paraffin-sections and whole mount retinas were incubated
overnight at 4uC with the following antibodies: goat anti-mouse a-
SMA (Abcam) at 1:100 dilution; rat anti-mouse Brn3a (Santa Cruz
Biotechnology, Inc, Heidelberg, Germany) at 1:100 dilution; rat
anti-mouse CD34 (Biolegend, San Diego, CA, USA) at 1:50
dilution; goat anti-mouse collagen IV (Millipore, Temecula, CA,
USA) at 1:200 dilution; goat anti-mouse Iba1 (Abcam) at 1:500
dilution; rabbit anti-mouse GFAP (DAKO) at 1:1000 dilution;
rabbit anti-mouse GS (Sigma-Aldrich) at 1:100 dilution; rabbit
anti-mouse Horse Spleen Ferritin (GeneTex, Irvine, CA, USA) at
1:100 dilution; rabbit anti-L-ferritin (Abcam) at 1:500 dilution;
mouse anti-mouse PKC (Sigma-Aldrich) at 1:500 dilution; rabbit
anti-Scara5 (LSBio, Seattle, WA, USA) at 1:200 dilution; rabbit
anti-mouse transferrin (Abcam) at 1:100 dilution; rabbit anti-
mouse transferrin receptor 1 (Abcam) at 1:100 dilution; rat anti-
mouse 2F8 (Serotec, Oxford, UK) at 1:100 dilution, and PNA
Lectin (Sigma-Aldrich) at 1:100 dilution. After they were washed
in PBS, the retinas were incubated at 4uC overnight with specific
secondary antibodies: biotinylated anti-goat (1:100) and anti-rabbit
(1:100) IgGs (Vector Laboratories, Burlingame, CA, USA). After
washing in PBS, streptavidin Alexa Fluor 488 and 546 conjugates
were used as fluorochromes (Invitrogen, Carlsbad, CA, USA) at
1:100 dilution; the incubation was made at 4uC overnight. Nuclear
counterstaining with To-Pro-3 (Invitrogen), at 1:100 dilution, or
with Hoechst stain solution (Sigma-Aldrich) was performed for
microscopic analysis with the laser scanning confocal microscope
(TCS SP2; Leica Microsystems GmbH, Heidelberg, Germany).
The 2F8 antibody was revealed with 3,39-diaminobenzidine (DAB)
and paraffin sections were counterstained with hematoxylin.
Procedural immunohistochemistry controls were done by omission
of the primary antibody in a sequential tissue section.
Figure 7. Intravenously injected HSF crossed the BRB. A: Six hours after the intravenous injection of HSF, western blotting analysis revealed
that HSF was present in the retina. As expected, a marked increase of L-ferritin content was also confirmed. B: The immunolabeling with a specific
anti-HSF antibody showed that HSF crossed the inner BRB and accumulated in mouse retina. HSF was internally lining the retinal blood vessels. C and
D: The double staining with anti-HSF and with anti-Scara5 antibodies showed that L-ferritin co-localized with endothelial cytoplasmic Scara5
(arrowhead), but no content of HSF was observed in RPE cells, suggesting a differential function of the inner and outer component of BRB. Nuclei
were counterstained with ToPro3. Con, non-injected control; Inj, injected; V, blood vessel; GL, ganglion cell layer; INL, inner nuclear layer; ONL, outer
nuclear layer; RPE, retinal pigment epithelium; CH, choroid. Scale bars: 24 mm (B); 10 mm (C); 8 mm (D).
doi:10.1371/journal.pone.0106974.g007
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Results
Scara5 was expressed in mouse retina
To investigate the presence of Scara5 in mouse retinal cells,
SCARA5 mRNA levels and Scara5 protein expression were
analyzed by means of q-RT-PCR and western blotting, respec-
tively. Liver was used as a positive control.
Our results revealed mRNA transcript and protein expression of
Scara5 in the retina (Figure 1A and B). The immunolabeling of
paraffin-embedded retinal sections with a specific anti-Scara5
antibody confirmed the expression of Scara5 throughout the
neuroretinal parenchyma and RPE. A stronger immunoreactivity
was observed at the ganglion cell layer, inner nuclear layer, outer
nuclear layer, and photoreceptor inner segments (Figure 1C). In
addition, Scara5 expression was detected both in the nucleus and
cytoplasm of retinal cells (Figure 2A).
To rule out the possibility of nonspecific labeling of the antibody
in the nucleus, nuclear and cytoplasmic protein fraction samples
were analyzed by western blotting. Our results confirmed that
Scara5 was expressed both at nuclear and cytoplasmic compart-
ments in retinal cells (Figure 2B).
Dual staining with specific markers (Brn3a, PKC and PNA
lectin) against retinal neurons [33,34,35] showed that ganglion
cells, bipolar cells and photoreceptors expressed Scara5 (Figure 3).
The content of Scara5 was higher in the inner segment of cones in
comparison with rods (Figure 3C). Scara5 was also expressed in
astrocytes, Mu¨ller cells and microglial cells, as shown by the co-
localization of anti-Scara5 antibody with anti-GFAP, anti-GS and
anti-Iba1 antibodies, respectively (Figure 4).
L-ferritin expression pattern in the retina
Since L-ferritin is the preferred ligand of Scara5 [23], we
explored L-ferritin expression and its spatial distribution along the
retinal parenchyma by means of q-RT-PCR, western blotting and
immunohistochemistry.
In agreement with previous studies [36,37], our results showed
FTL1 mRNA transcript and protein expression in the retina
(Figure 5A and B). Moreover, as occurred with Scara5, L-ferritin
was found both in nuclear and cytoplasmic compartments
(Figure 5C). Immunohistochemistry confirmed that L-ferritin
was present throughout the retinal parenchyma, with a higher
expression in the ganglion cell layer, outer plexiform layer, and
Figure 8. HSF influx into the retina changed Scara5, TfR1, and transferrin gene and protein expression. A: Relative expression of
SCARA5, TFRC, and TRF obtained from q-RT-PCR analysis. Y-axis indicates the relative expression distribution of a ratio of injected mice retinas versus
non-injected control mice retinas with ACTB and GAPDH as housekeeping genes. Boxes represent interquartile range, the median value is indicated
by horizontal dotted line, and whiskers represent the minimum and maximum observation. Statistical significance calculated by Rest 2009 (http://
www.REST.de.com) is indicated by *p,0,05, and ***p,0,001 (n = 12). Ratios over one indicate genes (SCARA5 and TFRC) with higher expression in
injected mice retinas relative to non-injected control mice retinas, and ratio less than one indicates gene (TRF) with lower expression in injected mice
retinas opposed to non-injected control mice retinas. Western blotting and immunohistochemistry analyses confirmed that HSF accumulation in the
retina was accompanied with an increased expression of Scara5 and TfR1 (B,C,D), and a slightly decrease of transferrin (B,E). Nuclei were
counterstained with ToPro3. Con, non-injected control; Inj, injected; GL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. Scale
bars: 25 mm (C); 28 mm (D); 30 mm (E).
doi:10.1371/journal.pone.0106974.g008
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photoreceptor inner segments. L-ferritin expression followed the
distribution pattern of Scara5 (Figure 5D).
Scara5 was detected in retinal vasculature
Since serum ferritin is mainly composed of L-ferritin [20,21], we
investigated the presence of Scara5 receptors in retinal blood
vessels as a possible pathway for serum ferritin influx into the
retina. The double immunostaining of paraffin-embedded mouse
retinal sections against Scara5 and collagen IV, a widely used
blood vessel basement membrane marker [38], Scara5 and CD34,
that has a strong expression in retinal endothelial cells [39], and
Scara5 and a-SMA, that in the retina is only found in vascular
smooth muscle cells [40], was performed.
Scara5 expression was detected in endothelial and smooth
muscle cells of retinal vasculature (Figure 6), suggesting that serum
ferritin could be transported across the BRB into the retinal
parenchyma by L-ferritin binding to Scara5. Moreover, in whole
mount retinas, astrocyte-like cells surrounding blood vessels also
expressed Scara5 (Figure 6D).
Serum ferritin influx into the retina
Due to the expression of Scara5 in endothelial cells, a possible
Scara5 pathway for ferritin influx into the retina was explored. In
order to test if serum ferritin crosses the BRB, mice were
intravenously injected with 40 mg of HSF. L-ferritin is the main
component of HSF [19]. Six hours after the injection, mice were
euthanized, retinas obtained, and Scara5, L-ferritin, TfR1, and
transferrin relative gene expression and protein levels were
assessed with q-RT-PCR and western blotting.
Our results showed that in healthy mice, without BRB
breakdown, intravenously injected HSF was taken up and
accumulated in the retina (Figure 7A and B). Interestingly, HSF
was lining the internal surface of retinal vessels (Figure 7B). When
Scara5 immunolabeling was performed in HSF injected retinas,
colocalization of HSF and cytoplasmic Scara5 was observed in
endothelial cells, suggesting that the binding between L-ferritin
and Scara5 may serve as a mechanism for serum ferritin transport
across the BRB (Figure 7C). The outer BRB barrier, the RPE,
expressed Scara5 (Figures 1C and 7D), but surprisingly HSF from
choroidal circulation was not detected in RPE cells, suggesting that
L-ferritin did not cross the outer BRB (Figure 7D).
Iron handling proteins are usually regulated by cytosolic iron
levels [7,41]. The study of HSF injected mice retinas by q-RT-
PCR revealed that TRF mRNA level was down-regulated ,0.8-
fold (P,0,037). In contrast, SCARA5 and TFRC mRNA levels
were up-regulated ,1.7-fold (P,0,0001) and ,1.4-fold (P,
0,039), respectively (Figure 8A). Similar results were obtained by
western blotting analyses (Figure 8B). The immunolabeling with
specific antibodies for Scara5, TfR1, and transferrin confirmed
this expression profile in HSF injected mice retinas (Figures 8C-E).
Altogether, these findings suggested that HSF, composed by L-
and H-ferritin, can cross the inner BRB through L-ferritin binding
to Scara5 and H-ferritin binding to TfR1 in retinal blood vessels.
Scara5 expression decreases during retinopathy
To investigate the possible involvement of Scara5 during
retinopathy, we used a murine model of retinopathy with
photoreceptor degeneration induced by the injection of sodium
iodate [29]. The toxicity of sodium iodate induces sequential
retinal structural and functional changes in a dose and time
dependent manner [42,43].
Figure 9. Murine model of retinopathy with photoreceptor degeneration. A: Forty-eight hours after sodium iodate injection, retinas
analyzed by western blotting showed an increased expression of GFAP. a-tubulin was used as a loading control. B: Paraffin-embedded retinal sections
stained with hematoxylin-eosin or immunolabeled with a specific anti-GFAP antibody revealed photoreceptor alterations and gliosis, indicating that
retinopathy was well established. Nuclei were counterstained with ToPro3. GL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer.
Scale bar: 35 mm.
doi:10.1371/journal.pone.0106974.g009
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Two groups of 6 mice each were intraperitoneally injected with
100 mg/kg of sodium iodate and euthanatized 24 and 48 hours
after treatment. A group injected only with PSS was used as
control. As expected, western blotting analysis and immunolabel-
ing with anti-GFAP antibody, revealed an increased expression of
GFAP (Figure 9A), and consequent gliosis (Figure 9B), indicating
that, 48 hours after treatment, retinopathy was well established.
Scara5 expression decreased approximately to a half during the
establishment of retinopathy (Figures 10A and B). The immuno-
labeling with anti-Scara5 antibody confirmed that expression of
this receptor decreased throughout the retina during retinopathy
(Figure 10C). Several Scara5 positive cells were found within the
outer nuclear layer (Figure 8C). The immunolabeling with anti-
2F8 antibody, a macrophage marker [44], revealed the presence of
2F8 positive cells also within the outer nuclear layer, suggesting
that the Scara5 positive cells observed may correspond to 2F8
positive macrophages that migrated to lesion sites [27].
Scara5 was expressed in human retinas
Scara5 has been described in several organs and cell lines [45],
but not in human retinas. To determine whether human retinas
may contain Scara5, paraffin-embedded human retinal sections
were analyzed by immunohistochemistry.
Scara5 immunostaining was observed throughout the entire
retina, at both cytoplasmic and nuclear levels, following the same
distribution pattern observed in mouse retinas (Figure 11).
Moreover, dual immunostaining for Scara5 and collagen IV,
GFAP, GS and Iba1 confirmed Scara5 expression in vessel wall
cells, astrocytes, Mu¨ller cells and microglia (Figure 11).
Discussion
There is a general consensus that, in the retina, iron is obtained
from the blood circulation through the classical transferrin
endocytosis pathway at the level of the RPE and the inner BRB
[4–6]. Recently, ferritin has been proposed as a new iron transport
protein [19]. Ferritin can sequester 2000-fold more iron than
transferrin [19], thus constituting a very efficient non-transferrin
source of iron to tissues. Serum ferritin, mainly constituted by L-
ferritin chains, is freely available in the bloodstream [46].
However, a ferritin pathway for iron delivery to the retina through
L-ferritin binding to Scara5 has not been identified until now.
Our results showed that Scara5 was present in mouse and
human retinas, throughout all the parenchyma layers, in different
cell types, including endothelial cells. The retinal distribution of L-
ferritin matched with that of its receptor Scara5. Furthermore,
intravenously injected L-ferritin, in the form of HSF, crossed the
inner BRB through its binding to Scara5 in endothelial cells, and
thereafter reached the retinal parenchyma. Thus, suggesting the
existence of a new pathway for iron delivery and trafficking in the
retina.
Iron is required for the nuclear metabolism [47]. However, iron
overload favors the production of reactive oxygen species. The
hydroxyl radical, produced in the presence of the ferrous iron, is a
powerful oxidizing agent who can promote mutagenesis, DNA
Figure 10. Scara5 expression decreased during retinopathy. A: Retinas of a sodium iodate murine model were analyzed by western blotting.
Scara5 expression reduced to about half during the treatment. B: Graph representing the optical density quantification of the Western blotting
analysis for Scara5, after normalization with respect to a-tubulin. C: The immunolabeling of paraffin-embedded retinal sections with anti-Scara5
antibody confirmed that Scara5 expression decreased throughout the parenchyma. However, several positive Scara5 cells were found in the outer
nuclear layer (arrowhead). D: During retinopathy, 2F8 positive cells were also observed in the outer nuclear layer (arrowhead), with a disposition
compatible with that of Scara5 positive cells. 2F8 was revealed by DAB reaction and histological sections were counterstained with hematoxylin. GL,
ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer. Scale bars: 45 mm (C); 20 mm (D).
doi:10.1371/journal.pone.0106974.g010
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strand breaks and activation of oncogenes [48]. Ferritin is present
in the nucleus to prevent iron-induced oxidative damage [48]. In
most tissues, nuclear ferritin is composed mainly by H-ferritin
[48,49], and some authors even deny the existence of L-ferritin in
the nucleus [50]. However, our results demonstrated an important
nuclear content of L-ferritin and its receptor Scara5 in retinal cells.
Although H-ferritin also has a nuclear localization in retinal cells
(data not shown), the presence of L-ferritin in the nuclei, with its
specific iron nucleation function, should be of importance for
counteracting the iron oxidative DNA damage.
Nuclear and cytoplasmic ferritins are the product of the same
mRNA [50], but the precise mechanism for cytosolic ferritin
translocation to the nucleus remains unclear [48]. The presence of
nuclear Scara5 may represent a possible involvement in ferritin
translocation to the nucleus.
Figure 11. Scara5 was expressed in human retinal cells. Laser confocal analysis of double-stained paraffin-embedded human retinal sections
with anti-Scara5 and anti-collagen IV, anti-GFAP, anti-GS and anti-Iba1 antibodies revealed that Scara5 was present throughout the retina, including
endothelial cells, astroctyes, Mu¨ller cells and microglial cells, following the distribution pattern observed in mouse retinas. D1, D2 and D3, 42, 78 and
86-years-old healthy human donors, respectively; GL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer.: 22 mm (A); 21 mm (B);
24 mm (C); 28 mm (D).
doi:10.1371/journal.pone.0106974.g011
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In the murine model of photoreceptor degeneration induced by
sodium iodate [29], Scara5 was downregulated. Thus, suggesting
less influx of serum ferritin into the retina, and consequently a
reduction in iron ligation. This decreased expression of Scara5
must be particularly harmful during iron acumulation conditions,
such as diabetic retinopathy [11], where unliganded or incomplete
liganded iron is associated with oxidative damage. This result
points out Scara5 receptors as potential players implicated in
retinopathy.
Scara5 is also downregulated in cancer, and the systemic
upregulation of Scara5, through the treatment with Scara5
liposome complex, markedly inhibits tumor growth in mice [51].
This feature opens the possibility for using Scara5 as a potential
therapeutic target to prevent free iron oxidative damage during
retinopathy.
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